{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:24:46Z","timestamp":1787221486083,"version":"build-2736575974"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008853","name":"Jining Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) has become a major driver of the growing global burden of chronic liver disease and has attracted increasing attention because of its progressive hepatic outcomes. Metabolic syndrome-related factors, such as obesity and abnormal glucose metabolism, confer on MASLD both a risk of liver disease progression and systemic metabolic consequences. Evidence from observational studies and experimental models suggests that infection and microbial exposure may be associated with MASLD progression and may modify its clinical course through alterations in the gut\u2013liver axis, enhanced immune activation, and amplification of metabolic inflammation. Meanwhile, the metabolic disturbances associated with MASLD can remodel the intestinal ecological niche and hepatic immune environment, impairing the host capacity to clear and regulate microbial signals and thereby altering infection susceptibility and clinical outcomes. Despite growing interest in infection and microbial dysbiosis in MASLD, most studies remain centered on individual pathogens. A unifying framework linking microbial exposure, host metabolic dysfunction, and inflammatory amplification is still lacking. For most infectious exposures, causal directionality and clinical modifiability remain uncertain. Accordingly, this review organizes the available evidence on the potential bidirectional relationships between infection and MASLD. It examines how gut\u2013liver microbial signals, viral comorbidities, chronic colonization, and acute infection may shape the course of MASLD. It also considers how MASLD-related metabolic dysfunction may, in turn, modify host responses to infection. Overall, incorporating infection and microbial dysbiosis into the conceptual framework of MASLD may help move beyond a metabolism-centered explanatory model and identify priorities for future risk-stratification and intervention studies.<\/jats:p>","DOI":"10.3389\/fcimb.2026.1932870","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:44:46Z","timestamp":1787219086000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Microbial exposure and host responses to infection reshape the disease trajectory of MASLD"],"prefix":"10.3389","volume":"16","author":[{"given":"Yunqi","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Xun","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhuang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyue","family":"Zang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwei","family":"Tan","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Cui","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiji","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15233","DOI":"10.3748\/wjg.v20.i41.15233","article-title":"Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3","volume":"20","author":"Abenavoli","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/jcpe.12800","article-title":"Periodontitis and non-alcoholic fatty liver disease, a population-based cohort investigation in the study of health in Pomerania","volume":"44","author":"Akinkugbe","year":"2017","journal-title":"J. Clin. Periodontol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/cells13110960","article-title":"Combined insults of a MASH diet and alcohol binges activate intercellular communication and neutrophil recruitment via the NLRP3-IL-1\u03b2 axis in the liver","volume":"13","author":"Babuta","year":"2024","journal-title":"Cells"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2331460","article-title":"Breaking the barriers: the role of gut homeostasis in metabolic-associated steatotic liver disease (MASLD)","volume":"16","author":"Bened\u00e9-Ubieto","year":"2024","journal-title":"Gut Microbes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14224","article-title":"The relevance of intestinal barrier dysfunction, antimicrobial proteins and bacterial endotoxin in metabolic dysfunction-associated steatotic liver disease","volume":"54","author":"Bergheim","year":"2024","journal-title":"Eur. J. Clin. Invest."},{"key":"B6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/liv.15815","article-title":"NAFLD and NASH are obesity-independent risk factors in COVID-19: Matched real-world results from the large PINC AI\u2122 Healthcare Database","volume":"44","author":"Brozat","year":"2024","journal-title":"Liver Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/v16010112","article-title":"Exploring Paxlovid efficacy in COVID-19 patients with MAFLD: Insights from a single-center prospective cohort study","volume":"16","author":"Buchynskyi","year":"2024","journal-title":"Viruses"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.106037","article-title":"Periodontitis exacerbates metabolic dysfunction-associated steatotic liver disease via the gut microbiota-derived tryptophan metabolism-AHR axis in obesity","volume":"122","author":"Chen","year":"2025","journal-title":"EBioMedicine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1186\/s12967-024-05506-y","article-title":"Helicobacter pylori infection exacerbates metabolic dysfunction-associated steatotic liver disease through lipid metabolic pathways: a transcriptomic study","volume":"22","author":"Chen","year":"2024","journal-title":"J. Transl. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1038\/s41467-022-31390-5","article-title":"Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome","volume":"13","author":"de Jonge","year":"2022","journal-title":"Nat. Commun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jhep.2021.11.029","article-title":"The fecal mycobiome in non-alcoholic fatty liver disease","volume":"76","author":"Demir","year":"2022","journal-title":"J. Hepatol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167343","article-title":"Exosomes derived from periodontitis induce hepatic steatosis through the SCD-1\/AMPK signaling pathway","volume":"1870","author":"Ding","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1016\/j.cgh.2023.05.013","article-title":"Risk of severe infection in patients with biopsy-proven nonalcoholic fatty liver disease - a population-based cohort study","volume":"21","author":"Ebrahimi","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.14744\/hf.2025.88386","article-title":"MASLD and viral hepatitis overlap: An emerging dual burden in chronic liver disease","volume":"7","author":"Ejaz","year":"2026","journal-title":"Hepatol. Forum"},{"key":"B15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/biomedicines11020271","article-title":"Hepatitis C virus-lipid interplay: Pathogenesis and clinical impact","volume":"11","author":"Elgretli","year":"2023","journal-title":"Biomedicines"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00073","article-title":"Helicobacter pylori infection is not associated with non-alcoholic fatty liver disease: A cross-sectional study in China","volume":"9","author":"Fan","year":"2018","journal-title":"Front. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1038\/s41467-023-39028-w","article-title":"Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae","volume":"14","author":"Gan","year":"2023","journal-title":"Nat. Commun."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405746121","article-title":"Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2","volume":"121","author":"Ganguly","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B19","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.cmet.2022.05.008","article-title":"MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH","volume":"34","author":"Gao","year":"2022","journal-title":"Cell Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jhep.2021.12.012","article-title":"Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease","volume":"76","author":"Govaere","year":"2022","journal-title":"J. Hepatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.3390\/jcm14103422","article-title":"When metabolic dysfunction-associated steatotic liver disease meets viral hepatitis","volume":"14","author":"Hasanoglu","year":"2025","journal-title":"J. Clin. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.clinre.2017.12.008","article-title":"Helicobacter pylori infection aggravates diet-induced nonalcoholic fatty liver in mice","volume":"42","author":"He","year":"2018","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03688-21","article-title":"Interleukin-17 weakens the NAFLD\/NASH process by facilitating intestinal barrier restoration depending on the gut microbiota","volume":"13","author":"He","year":"2022","journal-title":"mBio"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.gendis.2022.05.029","article-title":"Hepatocyte nuclear factor 1A suppresses innate immune response by inducing degradation of TBK1 to inhibit steatohepatitis","volume":"10","author":"He","year":"2023","journal-title":"Genes Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1016\/j.jfma.2022.07.013","article-title":"Metabolic dysfunction-associated fatty liver disease and chronic hepatitis B","volume":"121","author":"Huang","year":"2022","journal-title":"J. Formos Med. Assoc."},{"key":"B26","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3350\/cmh.2022.0422","article-title":"Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives","volume":"29","author":"Huang","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3350\/cmh.2024.0630","article-title":"MASLD after hepatitis C virus eradication: Do not overlook the cardiometabolic risk factors: Editorial on \"Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan","volume":"31","author":"Hui","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s42003-024-06357-5","article-title":"Egr2 drives the differentiation of Ly6C(hi) monocytes into fibrosis-promoting macrophages in metabolic dysfunction-associated steatohepatitis in mice","volume":"7","author":"Iwata","year":"2024","journal-title":"Commun. Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1111\/liv.15030","article-title":"Association between circulating bile acid alterations and nonalcoholic steatohepatitis independent of obesity and diabetes mellitus","volume":"41","author":"Jung","year":"2021","journal-title":"Liver Int."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000520","article-title":"Periodontal treatment and usual care for nonalcoholic fatty liver disease: A multicenter, randomized controlled trial","volume":"13","author":"Kamata","year":"2022","journal-title":"Clin. Transl. Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2025.101898","article-title":"Global burden and future trends of metabolic dysfunction-associated steatotic liver disease: 1990-2021 to 2045","volume":"30","author":"Kan","year":"2025","journal-title":"Ann. Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/s42255-025-01318-6","article-title":"Multi-omic analysis reveals transkingdom gut dysbiosis in metabolic dysfunction-associated steatotic liver disease","volume":"7","author":"Kim","year":"2025","journal-title":"Nat. Metab."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00535-017-1337-y","article-title":"A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease","volume":"52","author":"Kim","year":"2017","journal-title":"J. Gastroenterol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/v17020263","article-title":"The effects of pangenotypic direct-acting antiviral therapy on lipid profiles and insulin resistance in chronic hepatitis C patients","volume":"17","author":"Ko","year":"2025","journal-title":"Viruses"},{"key":"B35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.14218\/jcth.2015.00051","article-title":"Hepatitis C virus, insulin resistance, and steatosis","volume":"4","author":"Kralj","year":"2016","journal-title":"J. Clin. Transl. Hepatol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-024-00476-x","article-title":"Nisin lantibiotic prevents NAFLD liver steatosis and mitochondrial oxidative stress following periodontal disease by abrogating oral, gut and liver dysbiosis","volume":"10","author":"Kuraji","year":"2024","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1053\/j.gastro.2020.07.005","article-title":"Intestinal virome signature associated with severity of nonalcoholic fatty liver disease","volume":"159","author":"Lang","year":"2020","journal-title":"Gastroenterology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41467-025-67034-7","article-title":"Lack of intestinal Mucin-1 impairs intestinal epithelial barrier and promotes metabolic dysfunction-associated steatotic liver disease in male mice","volume":"17","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/infdis\/jiaa739","article-title":"Association between fatty liver and cirrhosis, hepatocellular carcinoma, and hepatitis B surface antigen seroclearance in chronic hepatitis B","volume":"224","author":"Li","year":"2021","journal-title":"J. Infect. Dis."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1347459","article-title":"Metabolic dysfunction-associated steatotic liver disease increases hepatocellular carcinoma risk in chronic hepatitis B patients: a retrospective cohort study","volume":"15","author":"Lin","year":"2024","journal-title":"Front. Physiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"6635","DOI":"10.1038\/s41467-023-42420-1","article-title":"RING finger protein 13 protects against nonalcoholic steatohepatitis by targeting STING-relayed signaling pathways","volume":"14","author":"Lin","year":"2023","journal-title":"Nat. Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3350\/cmh.2025.0155","article-title":"Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on \"Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C","volume":"31","author":"Liu","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jhep.2024.09.038","article-title":"Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infection","volume":"82","author":"Liu","year":"2025","journal-title":"J. Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41522-023-00399-z","article-title":"Gut microbiome determines therapeutic effects of OCA on NAFLD by modulating bile acid metabolism","volume":"9","author":"Liu","year":"2023","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1018322","article-title":"No evidence for a causal link between Helicobacter pylori infection and nonalcoholic fatty liver disease: A bidirectional Mendelian randomization study","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Microbiol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13911","article-title":"Infectious mononucleosis is associated with an increased incidence of NAFLD","volume":"53","author":"Loosen","year":"2023","journal-title":"Eur. J. Clin. Invest."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13827","article-title":"Microbial DNA enrichment promotes liver steatosis and fibrosis in the course of non-alcoholic steatohepatitis","volume":"235","author":"Luo","year":"2022","journal-title":"Acta Physiol. (Oxf)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16101","article-title":"Association between MASLD and increased risk of serious bacterial infections requiring hospital admission: A meta-analysis","volume":"45","author":"Mantovani","year":"2025","journal-title":"Liver Int."},{"key":"B49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12944-023-01957-2","article-title":"Effects of sustained viral response on lipid in hepatitis C: a systematic review and meta-analysis","volume":"23","author":"Mei","year":"2024","journal-title":"Lipids Health Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"688","DOI":"10.4254\/wjh.v16.i5.688","article-title":"Multifunctional role of oral bacteria in the progression of non-alcoholic fatty liver disease","volume":"16","author":"Mei","year":"2024","journal-title":"World J. Hepatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"6158","DOI":"10.3390\/jcm12196158","article-title":"Are selected cytokines and Epstein-Barr virus DNA load predictors of hepatological complications of Epstein-Barr virus infection in children","volume":"12","author":"Moppert","year":"2023","journal-title":"J. Clin. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3390\/life12060795","article-title":"Distinct cytokine profiles in severe COVID-19 and non-alcoholic fatty liver disease","volume":"12","author":"Papic","year":"2022","journal-title":"Life. (Basel)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.3390\/jcm14062013","article-title":"Effect of oral microbiota composition on metabolic dysfunction-associated steatotic liver disease in the general population","volume":"14","author":"Sato","year":"2025","journal-title":"J. Clin. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"13621","DOI":"10.1038\/s41598-022-17917-2","article-title":"A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal disease","volume":"12","author":"Sato","year":"2022","journal-title":"Sci. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.immuni.2024.01.009","article-title":"Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis","volume":"57","author":"Savage","year":"2024","journal-title":"Immunity"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1109762","article-title":"The value of bile acid spectrum in the evaluation of hepatic injury in children with infectious mononucleosis caused by Epstein Barr virus infection","volume":"11","author":"Shen","year":"2023","journal-title":"Front. Pediatr."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.5501\/wjv.v13.i1.91149","article-title":"Impact of metabolic dysfunction-associated steatotic liver disease on COVID-19 hospitalizations: A propensity-matched analysis of the United States","volume":"13","author":"Sohail","year":"2024","journal-title":"World J. Virol."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70059","article-title":"Risk of serious bacterial and non-bacterial infections in people with MASLD","volume":"45","author":"Targher","year":"2025","journal-title":"Liver Int."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106346","article-title":"Periodontitis salivary microbiota exacerbates nonalcoholic fatty liver disease in high-fat diet-induced obese mice","volume":"26","author":"Wang","year":"2023","journal-title":"iScience"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1016\/j.jhep.2022.10.009","article-title":"NAFLD was independently associated with severe COVID-19 among younger patients rather than older patients: A meta-analysis","volume":"78","author":"Wang","year":"2023","journal-title":"J. Hepatol."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07443-w","article-title":"Characterization of the gut virome in patients with nonalcoholic fatty liver disease","volume":"24","author":"Wang","year":"2025","journal-title":"J. Transl. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1038\/s12276-024-01280-5","article-title":"The Foxo1-YAP-Notch1 axis reprograms STING-mediated innate immunity in NASH progression","volume":"56","author":"Xu","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3349\/ymj.2014.55.1.107","article-title":"Clinical characteristics of primary Epstein Barr virus hepatitis with elevation of alkaline phosphatase and \u03b3-glutamyltransferase in children","volume":"55","author":"Yang","year":"2014","journal-title":"Yonsei Med. J."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2022.105040","article-title":"Porphyromonas gingivalis is a risk factor for the development of nonalcoholic fatty liver disease via ferroptosis","volume":"25","author":"Yao","year":"2023","journal-title":"Microbes Infect."},{"key":"B65","doi-asserted-by":"publisher","first-page":"19530","DOI":"10.1038\/s41598-022-23746-0","article-title":"Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trial","volume":"12","author":"Yu","year":"2022","journal-title":"Sci. Rep."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012377","article-title":"Gut mycobiome alterations and implications for liver diseases","volume":"20","author":"Zeng","year":"2024","journal-title":"PloS Pathog."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.809005","article-title":"Clinical characteristics and the risk factors of hepatic injury in 221 children with infectious mononucleosis","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Pediatr."},{"key":"B68","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s42255-024-01177-7","article-title":"Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis","volume":"7","author":"Zhang","year":"2025","journal-title":"Nat. Metab."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1016\/j.cmet.2024.08.012","article-title":"IL-22 resolves MASLD via enterocyte STAT3 restoration of diet-perturbed intestinal homeostasis","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metab."},{"key":"B70","doi-asserted-by":"publisher","first-page":"S182","DOI":"10.3350\/cmh.2024.0837","article-title":"Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B","volume":"31","author":"Zhang","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16136","article-title":"Metabolic dysfunction-associated steatotic liver disease increases the risk of severe infection: A population-based cohort study","volume":"45","author":"Zhao","year":"2025","journal-title":"Liver Int."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3390\/nu18111667","article-title":"Insulin-like growth factor 1 ameliorates intestinal barrier dysfunction in MASLD via IGF-1R\/PI3K\/AKT signaling","volume":"18","author":"Zhao","year":"2026","journal-title":"Nutrients"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1172\/jci150489","article-title":"ALK1 signaling is required for the homeostasis of Kupffer cells and prevention of bacterial infection","volume":"132","author":"Zhao","year":"2022","journal-title":"J. Clin. Invest."},{"key":"B74","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1186\/s12866-025-04348-y","article-title":"Characterization of the gut mycobiome in patients with non-alcoholic fatty liver disease and correlations with serum metabolome","volume":"25","author":"Zheng","year":"2025","journal-title":"BMC Microbiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3350\/cmh.2024.0047","article-title":"Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Zheng","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1038\/s41467-026-71981-0","article-title":"Multi-kingdom profiling reveals altered gut phage-bacteria-metabolite interactions in MASLD","volume":"17","author":"Zhou","year":"2026","journal-title":"Nat. Commun."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1932870\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:44:47Z","timestamp":1787219087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1932870\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":76,"alternative-id":["10.3389\/fcimb.2026.1932870"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1932870","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"article-number":"1932870"}}